v3.26.1
REVENUE RECOGNITION
 6 Months Ended
Jun. 27, 2026
Revenue from Contract with Customer [Abstract]  
REVENUE RECOGNITION REVENUE RECOGNITION
The following is a summary of our net sales by category (in millions):
Three Months EndedSix Months Ended
June 27, 2026June 28, 2025June 27, 2026June 28, 2025
Self Care
Upper Respiratory$178.4 $181.3 $375.7 $396.0 
Digestive Health115.7 119.8 212.4 232.6 
Healthy Lifestyle157.8 154.7 300.6 311.7 
Pain & Sleep124.6 142.8 231.2 272.5 
Total Self Care
$576.6 $598.6 $1,119.9 $1,212.8 
Specialty Care
Skin Health$161.8 $170.3 $313.7 $319.9 
Women's Health64.8 62.7 119.9 112.3 
Total Specialty Care
$226.6 $233.1 $433.6 $432.2 
Infant Formula $100.9 $82.0 $190.6 $169.8 
All Other(1)
$118.6 $142.7 $247.8 $285.4 
Total net sales$1,022.8 $1,056.3 $1,992.0 $2,100.2 
(1) Consists primarily of Oral Care, Dermacosmetics Business prior to sale (refer to Note 3 for details) and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales.
The following table provides information about contract assets from contracts with customers (in millions):
Balance Sheet LocationJune 27, 2026December 31, 2025
Short-term contract assetsPrepaid expenses and other current assets$40.1 $37.3 

We generated net sales in the following geographic locations(1) (in millions):
Three Months EndedSix Months Ended
June 27, 2026June 28, 2025June 27, 2026June 28, 2025
U.S.$626.4 $610.9 $1,180.8 $1,220.2 
Europe(2)
371.7 421.7 763.1 833.9 
All other countries(3)
24.7 23.7 48.1 46.1 
Total net sales$1,022.8 $1,056.3 $1,992.0 $2,100.2 
(1) The net sales by geography are derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $7.7 million and $11.8 million for the three and six months ended June 27, 2026, respectively, and $9.8 million and $20.8 million for the three and six months ended June 28, 2025, respectively. Refer to Note 3 for details regarding the divestment of the Dermacosmetics Business impacting net sales in Europe.
(3) Includes net sales generated primarily in Australia and Canada.